GILLIS STEVEN 4
4 · Codiak BioSciences, Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
GILLIS STEVEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-17+7,500→ 7,500 totalExercise: $2.83Exp: 2032-06-16→ Common Stock (7,500 underlying) - Award
Restricted Stock Units
2022-06-17+1,500→ 1,500 total→ Common Stock (1,500 underlying)
Footnotes (3)
- [F1]This option shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On June 17, 2022, the reporting person was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders.